⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6000096 | 0.96 | — | — | |
| SCHEMBL298779 | 0.79 | — | — | |
| SCHEMBL18670506 | 0.74 | HAO1 (0.43) | — | |
| SCHEMBL4957348 | 0.72 | TSHR (0.47) | — | |
| Oxalic Acid SCHEMBL27461073 | 0.72 | TSHR (0.83) | — | |
| SCHEMBL9651203 | 0.72 | TSHR (0.40) | — | |
| SCHEMBL9651208 | 0.72 | TSHR (0.40) | — | |
| SCHEMBL10507701 | 0.72 | TSHR (0.40) | — | |
| SCHEMBL6690358 | 0.72 | — | — | |
| Chloroacetic Acid SCHEMBL1330914 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720674-B | Modified chitosan, preparation method thereof, retarding water reducer and application | 科之杰新材料集团有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2024255217-A1 | MODIFIED CHITOSAN AND PREPARATION METHOD THEREFOR, AND RETARDATION-TYPE WATER-REDUCING AGENT AND USE THEREOF | 科之杰新材料集团有限公司 | 2024-12-19 | — | — | WO | claimed |
| CN-117720674-A | Modified chitosan, preparation method thereof, retarding water reducer and application | 科之杰新材料集团有限公司 | 2024-03-19 | — | — | CN | claimed |
| US-11077078-B2 | Compositions and methods for the treatment of cancer | KODISCOVERY, LLC (US) | 2021-08-03 | — | — | US | claimed |
| US-10500175-B2 | Compositions and methods for the treatment of cancer | KODISCOVERY, LLC (US) | 2019-12-10 | — | — | US | claimed |
| US-20190142775-A1 | TREATING ACTIVATED DERMAL CONDITIONS WITH AGENTS THAT TARGET ENERGY METABOLISM | SCIADERM, INC. | 2019-05-16 | — | — | US | claimed |
| EP-2063881-B1 | A COMPOSITION AND METHOD FOR THE EFFICACIOUS AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | KO YOUNG HEE (US) | 2019-05-08 | — | — | EP | claimed |
| EP-3452171-A1 | TREATING ACTIVATED DERMAL CONDITIONS WITH AGENTS THAT TARGET ENERGY METABOLISM | Sciaderm, Inc. (US) | 2019-03-13 | — | — | EP | claimed |
| US-20180311192-A1 | Compositions and Methods for the Treatment of Cancer | KODISCOVERY, LLC | 2018-11-01 | — | — | US | claimed |
| WO-2017192504-A1 | TREATING ACTIVATED DERMAL CONDITIONS WITH AGENTS THAT TARGET ENERGY METABOLISM | SCIADERM, INC. (US) | 2017-11-09 | — | — | WO | claimed |
| US-20070292478-A1 | Medical Implant Provided with Inhibitors of Atp Synthesis | INTERSTITIAL THERAPEUTICS (CH) | 2007-12-20 | — | — | US | claimed |
| WO-2007097989-A2 | A COMPOSITION AND METHOD FOR THE EFFICACIOUS AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | KO YOUNG HEE (US) | 2007-08-30 | — | — | WO | claimed |
| US-20070203074-A1 | Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer | KODISCOVERY, LLC | 2007-08-30 | — | — | US | claimed |
| EP-1789030-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | claimed |
| EP-1789107-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | claimed |
| WO-2006024488-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | claimed |
| WO-2006024492-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | claimed |
| US-20030087961-A1 | Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-08 | — | — | US | claimed |
| EP-0994094-A1 | Process for manufacturing 3-chloropyruvic acid | Nippon Sanso Corporation (JP) | 2000-04-19 | — | — | EP | claimed |
| US-4521534-A | Imidazo[2,1-a]pyrrolo[2,1-c][1,4]benzodiazepine derivatives, methods of preparation and use | AYERST, MCKENNA & HARRISON, LTD. (CA) | 1985-06-04 | — | — | US | claimed |